Related Experiment Videos
Amikacin synergism with beta-lactam antibiotics against selected nosocomial pathogens
Abstract:
The synergistic interaction between amikacin and several investigational antibiotics against seven different genera of nosocomial pathogens was assessed using the microtitre checkerboard technique. The greatest percentage of tests showing synergy was when amikacin was used in combination with apalcillin and azlocillin particularly against Serratia marcescens and Proteus spp. When amikacin was combined with several new semi-synthetic cephalosporins, synergy was present in a variable percentage of tests. No antagonism was found in any of the tested combinations.
Insights
Amikacin combined with apalcillin and azlocillin showed significant synergy against nosocomial pathogens like Serratia marcescens. This antibiotic combination offers a promising strategy for combating difficult-to-treat infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Nosocomial pathogens pose a significant threat in healthcare settings.
- The rise of antibiotic resistance necessitates the development of novel therapeutic strategies.
- Amikacin is a widely used aminoglycoside antibiotic.
Purpose of the Study:
- To evaluate the synergistic interactions between amikacin and investigational antibiotics.
- To determine the efficacy of antibiotic combinations against common nosocomial pathogens.
- To identify optimal antibiotic combinations for enhanced antimicrobial activity.
Main Methods:
- Microtitre checkerboard technique was employed to assess drug interactions.
- Seven different genera of nosocomial pathogens were utilized in the study.
- Combinations of amikacin with apalcillin, azlocillin, and semi-synthetic cephalosporins were tested.
Main Results:
- Synergistic interactions were observed between amikacin and several investigational antibiotics.
- The combination of amikacin with apalcillin and azlocillin demonstrated the highest synergy rates.
- Synergy was particularly noted against Serratia marcescens and Proteus spp.
- Variable synergy was observed with semi-synthetic cephalosporins.
- No antagonistic effects were detected in any tested combination.
Conclusions:
- Combination therapy with amikacin and certain investigational antibiotics, notably apalcillin and azlocillin, shows significant synergistic potential.
- These findings suggest promising new treatment options for infections caused by resistant nosocomial pathogens.
- Further clinical investigation is warranted to validate these synergistic combinations in patient care.